Clinical trials
Carcinoma, Renal Cell trials in China with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
33 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2018 | 2 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 7 |
| 2025 | 5 |
| 2026 | 7 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 14 |
| Unknown status | 12 |
| Completed | 4 |
| Not yet recruiting | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Peking University First Hospital | 5 |
| RenJi Hospital | 4 |
| The First Affiliated Hospital with Nanjing Medical University | 3 |
| Peking Union Medical College Hospital | 2 |
| Sun Yat-sen University | 2 |
| The Affiliated Hospital of Qingdao University | 2 |
| Chinese PLA General Hospital | 1 |
| Fuda Cancer Hospital, Guangzhou | 1 |
| Guangdong Provincial People's Hospital | 1 |
| Huazhong University of Science and Technology | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Renal Cell | 33 |
| Kidney Neoplasms | 4 |
| Adrenal Gland Neoplasms | 2 |
| Breast Neoplasms | 2 |
| Carcinoma, Hepatocellular | 2 |
| Carcinoma, Non-Small-Cell Lung | 2 |
| Colorectal Neoplasms | 2 |
| Prostatic Neoplasms | 2 |
| Urinary Bladder Neoplasms | 2 |
| Acute Kidney Injury | 1 |
Trials
Showing 1 to 25 of 33. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.